Skip to main content
Log in

Evaluation of the Ergogenic Properties of Ginseng

An Update

  • Review Article
  • Published:
Sports Medicine Aims and scope Submit manuscript

Abstract

Ginseng has been used in the Orient for several thousand years as an ‘adaptogenic’ as well as a ‘restorative’ agent. It has been used to treat nervous disorders, anaemia, wakefulness, dyspnoea, forgetfulness and confusion, prolonged thirst, decreased libido, chronic fatigue, angina and nausea. Although the mechanisms underlying the alleged effects of ginseng remain to be elucidated, there is an extensive animal literature dealing with the effects of ginseng on the cardiovascular system, central nervous system, endocrine system, metabolism, and immune system. In our previous review dealing with the efficacy of ginseng, we concluded that while studies with animals show that ginseng, or its active components, may prolong survival to physical or chemical stress, there is generally a lack of controlled research demonstrating the ability of ginseng to improve or prolong performance in fatigued humans. In this review, we extend our earlier analysis on the potential efficacy of ginseng use in the enhancement of physical performance and modification of fatigue states. Our analysis reveals that published literature appearing since our earlier review has not resolved the equivocal nature of research evidence involving animals or humans. Also, the lack of unanimity in this research can be explained on the basis of various methodological problems such as inadequate sample size and lack of double-blind, control and placebo paradigms. In addition, the absence of acceptable approaches to the problem of ‘sourcing’, in concert with an absence of compliance data in human research, further complicates the interpretation of this research literature. Nevertheless, the use of ginseng continues to grow, and current sales are estimated to be over $US300 million annually. There is clearly a need for systematic research dealing with the efficacy of ginseng, and this research needs to take into account basic, fundamental design considerations if there is to be any hope of establishing whether or not ginseng possesses efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I.

Similar content being viewed by others

Notes

  1. G115 is the registered trademark of a ginseng extract containing all 13 ginsenosides from the Korean Panax ginseng. This extract is marketed as Ginsana (GPL Ginsana Products SA, Lugano, Switzerland).

References

  1. Horowitz B. Tea maker’s herbal addition: firm trying to supplement sales. USA Today 1998 April 14; 4B

    Google Scholar 

  2. Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 1995; 273 (8): 607–9

    PubMed  CAS  Google Scholar 

  3. Miller LG. Herbal medicinals. Arch Intern Med 1998; 158 (20): 2200–11

    PubMed  CAS  Google Scholar 

  4. Richman A, Witkowski J. Herbs by the numbers. Whole Foods Magazine 1997; 20, 22, 24, 26, 28

    Google Scholar 

  5. Hellmich N. Herbal remedies take root, flourish. USA Today 1998 Dec 29; 6D

    Google Scholar 

  6. Deveny K. Garlic pills are potent drugstore sellers. Wall Street J 1992 Oct 1; B1, B14

    Google Scholar 

  7. Goldstein B. Ginseng: its history, dispersion, and folk tradition. Am J Chin Med 1975; 3 (3): 223–34

    PubMed  CAS  Google Scholar 

  8. Hu SY. A contribution to our knowledge of ginseng. Am J Chin Med 1977; 5 (1): 1–23

    PubMed  CAS  Google Scholar 

  9. Liu C-X, Xiao P-G. Recent advances in ginseng research in China. J Ethnopharmacol 1992; 36: 27–38

    PubMed  CAS  Google Scholar 

  10. Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969; 9: 419–30

    PubMed  CAS  Google Scholar 

  11. Cartwright L. Ginseng in pharmacies. Aust J Pharm 1979; 60: 346–9

    CAS  Google Scholar 

  12. Hu SY. The genus Panax (ginseng) in Chinese medicine. Econ Botany 1976; 30: 11–28

    Google Scholar 

  13. Li CP, Li RC. An introductory note to ginseng. Am J Chin Med 1973; 1 (2): 249–61

    PubMed  CAS  Google Scholar 

  14. Perry LM, Metzger J. Medicinal plants of east and southeast asia: attributed properties and uses. Cambridge (MA): MIT Press, 1980

    Google Scholar 

  15. Baranov A. Recent advances in our knowledge of the morphology, cultivation and uses of ginseng (Panax ginseng C.A. Meyer). Econ Botany 1966; 20: 403–6

    Google Scholar 

  16. Bittles AH, Fulder SJ, Grant EC, et al. The effect of ginseng on lifespan and stress responses in mice. Gerontology 1979; 25: 125–31

    PubMed  CAS  Google Scholar 

  17. Popov IM, Goldwag WJ. A review of the properties and clinical effects of ginseng. Am J Chin Med 1973; 1 (2): 263–70

    PubMed  CAS  Google Scholar 

  18. Phillipson JD, Anderson LA. Ginseng: quality, safety, and efficacy? Pharm J 1984; 232: 161–5

    CAS  Google Scholar 

  19. Bahrke MS, Morgan WP. Evaluation of the ergogenic properties of ginseng. Sports Med 1994; 18 (4): 229–48

    PubMed  CAS  Google Scholar 

  20. Pietta P, Mauri P, Rava A. Improved high-performance liquid chromatographic method for the analysis of ginsenosides in Panax ginseng extracts and products. J Chromatogr 1986; 356: 212–9

    PubMed  CAS  Google Scholar 

  21. Barna P. Food or drug? The case of ginseng [letter]. Lancet 1985; II: 548

    Google Scholar 

  22. Court WE. Ginseng: a Chinese folk medicine of current interest. Pharm J 1975; 214: 180–1

    Google Scholar 

  23. Williams LO. Ginseng. Econ Botany 1957; 11: 344–8

    Google Scholar 

  24. Baranov AI. Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature. J Ethnopharmacol 1982; 6: 339–53

    PubMed  CAS  Google Scholar 

  25. Brekhman II. Eleutherococcus senticosus: a new medicinal herb of the araliaceae family. In: Chen KK, Mukerji B, editors. Pharmacology of oriental plants. New York (NY):Macmillan Company, 1965: 97–102

    Google Scholar 

  26. Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci 1978; 67 (10): 1487–9

    PubMed  CAS  Google Scholar 

  27. Hou JP. The chemical constituents of ginseng plants. Comp Med East West 1977; 5 (2): 123–45

    PubMed  CAS  Google Scholar 

  28. Iwabuchi H, Yoshikura M, Ikawa Y, et al. Studies on the sesquiterpenoids of Panax ginseng C.A.Meyer: isolation and structure determination of sesquiterpene alcohols, panasinsanols A and B. Chem Pharm Bull 1987; 35 (5): 1975–81

    PubMed  CAS  Google Scholar 

  29. Iwabuchi H, Yoshikura M, KamisakoW. Studies on the sesquiterpenoids of Panax ginseng C.A. Meyer II: isolation and structure determination of ginsenol, a novel sesquiterpene alcohol. Chem Pharm Bull 1988; 36 (7): 2447–51

    PubMed  CAS  Google Scholar 

  30. Kasai R, Yamaguchi H, Tanaka O. High-performance liquid chromatography of glycosides on a new type of hydroxyapatite column. J Chromatogr 1987; 407: 205–10

    PubMed  CAS  Google Scholar 

  31. Shibata S, Fujita M, Itokawa H, et al. Studies on the constituents of Japanese and Chinese crude drugs: XI. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull 1963; 11 (6): 759–61

    PubMed  CAS  Google Scholar 

  32. Tanaka O, Nagai M, Shibata S. Chemical studies on the Oriental plant drugs: XVI. The stereochemistry of protopanaxadiol, a genuine sapogenin of ginseng. Chem Pharm Bull 1966; 14 (10): 1150–6

    PubMed  CAS  Google Scholar 

  33. Yamaguchi H, Kasai R, Matsuura H, et al. High-performance liquid chromatographic analysis of acidic saponins of ginseng and related plants. Chem Pharm Bull 1988; 36 (9): 3468–73

    PubMed  CAS  Google Scholar 

  34. Iida Y, Tanaka O, Shibata S. Studies on saponins of ginseng: the structure of ginsenoside-Rg1. Tetrahedron Lett 1968; 52: 5449–53

    Google Scholar 

  35. Shibata S, Tanaka O, Soma K, et al. Studies on saponins and sapogenins of ginseng: the structure of panaxatriol. Tetrahedron Lett 1965; 3: 207–13

    Google Scholar 

  36. Besso H, Kasai R, Wei J, et al. Further studies on dammaranesaponins of American ginseng, roots of Panax quinquefolium L. Chem Pharm Bull 1982; 30 (12): 4534–8

    CAS  Google Scholar 

  37. Elyakov GB, Strigina LI, Uvarova NI, et al. Glycosides from ginseng roots. Tetrahedron Lett 1964; 48: 3591–7

    Google Scholar 

  38. Petkov VD, Yinglin C, Todorov I, et al. Behavioral effects of stem-leaves extract from Panax ginseng C.A. Meyer. Acta Physiol Pharmacol Bulg 1992; 18 (2): 41–8

    PubMed  CAS  Google Scholar 

  39. Chong SKF, Oberholzer VG. Ginseng: is there a use in clinical medicine? Postgrad Med J 1988; 64: 841–6

    PubMed  CAS  Google Scholar 

  40. Matsuda H, Namba K, Fukuda S, et al. Pharmacological study on Panax ginseng C.A. Meyer: III. Effects of red ginseng on experimental disseminated intravascular coagulation. (2). Effects of ginsenosides on blood coagulative and fibrinolytic systems. Chem Pharm Bull 1986; 34 (3): 1153–7

    PubMed  CAS  Google Scholar 

  41. Mattei R, Dias RF, Espinola EB, et al. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidant activity in vitro. J Ethnopharmacol 1998; 60 (2): 111–6

    PubMed  CAS  Google Scholar 

  42. Wang LCH, Lee T-F. Effect of ginseng saponins on exercise performance in non-trained rats. Planta Med 1998; 64: 130–3

    PubMed  CAS  Google Scholar 

  43. Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and ginseng. J Ethnopharmacol 1994; 44 (3): 131–5

    PubMed  CAS  Google Scholar 

  44. Nitta H, Matsumoto K, Shimizu M, et al. Panax ginseng extract improves the performance of aged Fischer 344 rats in radial maze task but not in operant brightness discrimination task. Biol Pharm Bull 1995; 18 (9): 1286–8

    PubMed  CAS  Google Scholar 

  45. Huong NTT, Matsumoto K, Yamasaki K, et al. Crude saponin extracted from Vietnamese ginseng and its major constituent majonoside-R2 attenuate the psychological stress- and foot-shock stress-induced antinociception in mice. Pharmacol Biochem Behav 1995; 52 (2): 427–32

    CAS  Google Scholar 

  46. Sorensen H, Sonne J. A double-masked study of the effects of ginseng on cognitive functions. Curr Ther Res 1996; 57 (12): 959–68

    Google Scholar 

  47. Wesnes KA, Faleni RA, Hefting NR, et al. The cognitive, subjective, and physical effects of a Ginko biloba/Panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacol Bull 1997; 33 (4): 677–83

    PubMed  CAS  Google Scholar 

  48. Thommessen B, Laake K. Ginseng: no identifiable effect in geriatric rehabilitation. Tidsskr Nor Laegeforen 1997; 117 (26): 3839–41

    PubMed  CAS  Google Scholar 

  49. Smith K, Engels H-J, Martin J, et al. Efficacy of a standardized ginseng extract to alter psychological function characteristics at rest and during exercise stress [abstract]. Med Sci Sports Exerc 1995; 27 (5) Suppl.: S147

    Google Scholar 

  50. Marasco A, Ruiz R, Villagomez A, et al. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp Clin Res 1996; 22 (6): 323–9

    Google Scholar 

  51. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995; 18 (10): 1373–5

    PubMed  CAS  Google Scholar 

  52. Han KH, Choe SC, Kim HS, et al. Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am J Chin Med 1998; 26 (2): 199–209

    PubMed  CAS  Google Scholar 

  53. Macaraeg PVJ, Ramos E. The effect of ginseng on exercise duration [abstract]. The XXIII FIMS World Congress of Sports Medicine Abstracts 1986. Champaign (IL): Fédération Internationale de Médicine Sportive, 1986: 151

    Google Scholar 

  54. Ng CC, Ng YK. The effect of ginseng: a traditional Chinese medicine on physical capacity [abstract]. The XXIII FIMS World Congress of Sports Medicine Abstracts 1986. Champaign (IL): Fédération Internationale de Médicine Sportive, 1986: 196

    Google Scholar 

  55. McNaughton L, Egan G, Caelli G. A comparison of Chinese and Russian ginseng as ergogenic aids to improve various facets of physical fitness. Int Clin Nutr Rev 1989; 9 (1): 32–5

    Google Scholar 

  56. Gribaudo CG, Ganzit GP, Verzini EF. Effetti sulla forza e sulla fatica muscolare di un prodotto ergogenico di origine naturale. Med Dello Sport 1990; 43 (4): 241–9

    Google Scholar 

  57. Gribaudo CG, Ganzit GP, Biancotti PP, et al. Effetti della somministrazione di un prodotto naturale ergogenico sulle doti aerobiche di ciclisti agonisti. Med Dello Sport 1991; 44 (4): 335–43

    Google Scholar 

  58. Morris AC, Jacobs I, McLellan TM, et al. No ergogenic effect of ginseng ingestion. Int J Sport Nutr 1996; 6: 263–71

    PubMed  CAS  Google Scholar 

  59. Lifton B, Otto RM, Wygand J. The effect of ginseng on acute maximal aerobic exercise [abstract]. Med Sci Sports Exerc 1997; 29 (5) Suppl.: S249

    Google Scholar 

  60. Allen JD, McLung J, Nelson AG, et al. Ginseng supplementation does not enhance healthy young adults’ peak aerobic exercise performance. J Am Coll Nutr 1998; 17 (5): 462–6

    PubMed  CAS  Google Scholar 

  61. Engels H-J, Said JM, Wirth JC. Failure of chronic ginseng supplementation to affect work performance and energy metabolism in healthy adult females. Nutr Res 1996; 16 (8): 1295–305

    Google Scholar 

  62. Engels H-J, Said J, Wirth JC, et al. Effect of chronic ginseng intake on metabolic responses during and in the recovery from graded maximal exercise [abstract]. Med Sci Sports Exerc 1995; 27 (5) Suppl.: S147

    Google Scholar 

  63. Engels H-J, Feng S, Chen Y. Effect of ginseng (G115) on maximal aerobic exercise performance in aerobically fit young adults [abstract]. The XXVI FIMS World Congress of Sports Medicine Abstracts 1998; Champaign (IL): Fédération Internationale de Médicine Sportive, 1998: 33

    Google Scholar 

  64. Engels H-J, Wirth JC. No ergogenic effects of ginseng (Panax Ginseng C.A. Meyer) during graded maximal aerobic exercise [abstract]. Int J Sport Nutr 1998; 8: 202

    Google Scholar 

  65. Kolokouri I, Engels H-J, Cieslak T, et al. Effect of chronic ginseng supplementation on short duration, supramaximal exercise test performance [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S117

    Google Scholar 

  66. Asano K, Takahashi T, Miyashita M, et al. Effect of Eleutheroccocus senticosus extract on human physical working capacity. Planta Med 1986; 3: 175–7

    PubMed  Google Scholar 

  67. Dowling EA, Redondo DR, Branch JD, et al. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Med Sci Sports Exerc 1996; 28 (4): 482–9

    PubMed  CAS  Google Scholar 

  68. Eschbach LC, Webster MJ, Boyd JC, et al. The effect of Eleutherococcus senticosus (Siberian ginseng) on substrate utilization and performance during prolonged cycling [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S117

    Google Scholar 

  69. Morgan WP. Methodological considerations. In: Morgan WP, editor. Physical activity and mental health. Washington, DC: Taylor and Francis, 1997: 3–32

    Google Scholar 

  70. Siegel RK. Ginseng abuse syndrome: problems with the panacea. JAMA 1979; 241 (15): 1614–5

    PubMed  CAS  Google Scholar 

  71. Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 1999; 56: 125–38

    PubMed  CAS  Google Scholar 

  72. Ryu S-J, Chien Y-Y. Ginseng-associated cerebral arteritis. Neurology 1995; 45: 829–30

    PubMed  CAS  Google Scholar 

  73. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692–3

    PubMed  CAS  Google Scholar 

  74. Sirdofsky M, Kattah J, Macedo P. Intracranial hypertension in a dieting patient. J Neurol Ophthalmol 1994; 14 (1): 9–11

    CAS  Google Scholar 

  75. Baldwin CA, Anderson LA, Phillipson JD. What pharmacists should know about ginseng. Pharm J 1986; 237: 583–6

    Google Scholar 

  76. Owen RT. Ginseng: a pharmacological profile. Drugs Today 1981; 17: 343–51

    CAS  Google Scholar 

  77. Johnston BA. One-third of nation’s adults use herbal remedies. Herbalgram 1997; 40: 49

    Google Scholar 

  78. Li TSC, Mazza G, Cottrell AC, et al. Ginsenosides in roots and leaves of American ginseng. J Agric Food Chem 1996; 44 (3): 717–20

    CAS  Google Scholar 

  79. Smith RG, Caswell D, Carriere A, et al. Variation in the ginsenoside content of American ginseng, Panax quinquefolius Lroots. Can J Bot 1996; 74: 1616–20

    CAS  Google Scholar 

  80. Vigano C, Ceppi E. What is in ginseng [letter]? Lancet 1994; 344 (8922): 619

    PubMed  CAS  Google Scholar 

  81. Walker AF. What is in ginseng [letter]? Lancet 1994; 344 (8922): 619

    PubMed  CAS  Google Scholar 

  82. Awang DVC. Siberian ginseng toxicity may be case of mistaken identity [letter]. Can Med J 1996; 155 (9): 1237

    CAS  Google Scholar 

  83. Bahrke MS. Ginseng: a root just like a carrot [letter]. J R Soc Med 1995; 88: 304

    PubMed  CAS  Google Scholar 

  84. Bahrke MS. Comments on ‘Manic episode and ginseng: report of a possible case’ [letter]. J Clin Psychopharmacol 1997; 17 (2): 140–1

    PubMed  CAS  Google Scholar 

  85. Becker BN, Greene J, Evanson J, et al. Ginseng-induced diuretic resistance [letter]. JAMA 1996; 276 (8): 606–7

    PubMed  CAS  Google Scholar 

  86. Chosidow O, Dega H, Peytavin G. Authors’ reply [letter]. Lancet 1996; 348: 267

    Google Scholar 

  87. Dega H, Laporte J-L, Frances C, et al. Ginseng as a cause for Stevens-Johnson syndrome [letter]? Lancet 1996; 347: 1344

    PubMed  CAS  Google Scholar 

  88. Faleni R, Soldati F. Ginseng as cause of Stevens-Johnson syndrome [letter]? Lancet 1996; 348: 267

    PubMed  CAS  Google Scholar 

  89. Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case [letter]. J Clin Psychopharmacol 1995; 15 (6): 447–8

    PubMed  CAS  Google Scholar 

  90. Huxtable RJ. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med 1992; 117: 165–6

    PubMed  CAS  Google Scholar 

  91. Hammond TG, Whitworth JA. Adverse reactions to ginseng [letter]. Med J Aust 1981 May 2; 492

  92. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996; 155 (3): 293–5

    CAS  Google Scholar 

  93. Wilkie A, Cordes C. Ginseng: a root just like a carrot [letter]? J R Soc Med 1994; 87 (10): 594–5

    PubMed  CAS  Google Scholar 

  94. Cui J-F. Identification and quantification of ginsenosides in various commercial ginseng preparations. Euro J Pharm Sci 1995; 3 (2): 77–85

    CAS  Google Scholar 

  95. Cui J-F, Garle M, Bjokhem I, et al. Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng. Scand J Clin Lab Invest 1996; 56: 151–60

    PubMed  CAS  Google Scholar 

  96. Vaughan MA, Doolittle RL, Gennett T, et al. Physiological effects of ginseng may be due to methylxanthines [abstract]. Med Sci Sports Exerc 1999; 31 (5) Suppl.: S121

    Google Scholar 

  97. Matsunaga H, Katano M, Yamamoto H, et al. Cytotoxic activity of polyacetylene compounds in Panax ginseng C.A. Meyer. Chem Pharm Bull 1990; 38: 3480–2

    PubMed  CAS  Google Scholar 

  98. Madison WI. Officials question purity of ginseng: regulators find use of illegal pesticides. Capital Times 1997 Oct 7

  99. Cable News Network. Company says ginseng batch contaminated [online]. Available from: http://cnn.com/HEALTH/9805/21/tainted.ginseng/index.html [Accessed 1999 Dec 15]

  100. Ginseng warning. USA Today 1997 Dec 19; 3A

    Google Scholar 

  101. Watt J, Bottomly MB, Read MTF. Olympic athletics medical experience. Seoul: personal views. Br J Sports Med 1989; 23 (2): 76–9

    PubMed  CAS  Google Scholar 

  102. Fuentes RJ, Rosenberg JM, Davis A, editors. Athletic drug reference. Durham (NC): Clean Data Inc., 1996

    Google Scholar 

  103. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997; 54 (1): 1–8

    PubMed  CAS  Google Scholar 

  104. Trine MR. Physical activity and quality of life. In: Rippe JM, editor. Lifestyle medicine. Malden (MA): Blackwell Scientific Publications, 1999: 989–99

    Google Scholar 

  105. Wiklund I, Karlberg J, Lund B. A double-blind comparison of the effect on quality of life of a combination of vital substances including standardized ginseng G115 and placebo. Curr Ther Res 1994; 55 (1): 32–42

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael S. Bahrke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bahrke, M.S., Morgan, W.P. Evaluation of the Ergogenic Properties of Ginseng. Sports Med 29, 113–133 (2000). https://doi.org/10.2165/00007256-200029020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00007256-200029020-00004

Keywords

Navigation